Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma

Hematologic Oncology Update

00:00

Cell Anexor

The CR-8 may still be limited. You just, as you said, have to really accompany patients with supportive MOSU has nurses, more or two, in the patient for their weight, for their appetite and other drugs that will fight against this syndrome of waste. The question is, you know, you have a 30% response rate. Maybe if you give it with more supportive, more zero, you will have a little bit of increase of that.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app